Drug repositioning and repurposing: terminology and definitions in literature

Publication date

2015-08

Authors

Langedijk, JorisISNI 000000049322810X
Mantel - Teeuwisse, AukjeISNI 0000000390595150
Slijkerman, Diederick S
Schutjens, Marie Hélène D.B.ISNI 0000000032064480

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

taverne

Abstract

Drug repositioning and similar terms have been a trending topic in literature and represent novel drug development strategies. We analysed in a quantitative and qualitative manner how these terms were used and defined in the literature. In total, 217 articles referred to 'drug repositioning', 'drug repurposing', 'drug reprofiling', 'drug redirecting' and/or 'drug rediscovery'. Only 67 included a definition ranging from brief and general to extensive and specific. No common definition was identified. Nevertheless, four common features were found: concept, action, use and product. The different wording used for these features often leads to essential differences in meaning between definitions. In case a clear definition is needed, for example from a legal or regulatory perspective, the features can provide further guidance.

Keywords

Taverne

Citation

Langedijk, J, Mantel-Teeuwisse, A K, Slijkerman, D S & Schutjens, M-H D B 2015, 'Drug repositioning and repurposing: terminology and definitions in literature', Drug Discovery Today, vol. 20, no. 8, pp. 1027-1034. https://doi.org/10.1016/j.drudis.2015.05.001